Yüklüyor......

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials

The results of our third trial on epicutaneous allergen-specific immunotherapy (EPIT) will be presented and discussed in the context of our previous trials. This monocentric, placebo-controlled, double-blind phase I/IIa trial included 98 patients with grass pollen rhinoconjunctivitis. Prior to the p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Allergy
Asıl Yazarlar: Senti, G, von Moos, S, Tay, F, Graf, N, Johansen, P, Kündig, T M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Publishing Ltd 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654258/
https://ncbi.nlm.nih.gov/pubmed/25704072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.12600
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!